Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 20,000 shares at $25.00 ($500K) on 2014-09-26, disclosed to the SEC on 2014-09-30.
Scheduled sale ($500k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |